Pfizer Inc.PFENYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank71
3Y CAGR-21.4%
5Y CAGR+9.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-21.4%/yr
vs +24.3%/yr prior
5Y CAGR
+9.5%/yr
Recent deceleration
Acceleration
-45.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $18.57B | -14.8% |
| 2024 | $21.78B | -25.4% |
| 2023 | $29.21B | -23.6% |
| 2022 | $38.24B | +11.1% |
| 2021 | $34.41B | +192.4% |
| 2020 | $11.77B | -6.7% |
| 2019 | $12.62B | -21.1% |
| 2018 | $16.01B | +1.5% |
| 2017 | $15.78B | -1.1% |
| 2016 | $15.95B | - |